Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment

Digestive and Liver Disease

Volumn 42, Issue 5, 2010, Pages 352-358

  Sugai, Emilia ^a   Nachman, Fabio ^a   Váquez, Horacio ^a   González, Andrea ^a   Andrenacci, Paola ^a   Czech, Andrea ^a   Niveloni, Sonia ^a   Mazure, Roberto ^a   Smecuol, Edgardo ^a   Cabanne, Ana ^a   Mauriño, Eduardo ^a   Bai, Julio Cesar ^a  

^a HOSPITAL DE GASTROENTEROLOGÍA DR CARLOS BONORINO UDAONDO   (Argentina)

Author keywords

Antibodies; Antigliadin antibodies; Celiac disease; Gluten free diet; Peptide antibodies; Serology; Tissue transglutaminase

Indexed keywords

ACTIN ANTIBODY; ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CELIAC DISEASE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTEN FREE DIET; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SEROLOGY;

ADOLESCENT; ADULT; AGED; ANTIBODIES; CELIAC DISEASE; DIET, GLUTEN-FREE; FEMALE; GLIADIN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 77951629788     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.07.011     Document Type: Article

References (32)

1. Fasano A., Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001, 120:636-651.
2. Green P.H.R., Rostami K., Marsh M.N. Diagnosis of celiac disease. Best Pract Res 2005, 19:389-400.
3. American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Celiac Disease. Gastroenterology 2006, 131:1981-2002.
4. Corazza G.R., Biagi F., Andreani M.L., Gasbarrini G. Screening test for coeliac disease. Lancet 1997, 349:325-326.
5. Rostom A., Dubé C., Cranney A., et al. The diagnostic accuracy of serologic tests for celiac disease: a systemic review. Gastroenterology 2005, 128:S38-S46.
6. Dieterich W., Laag E., Schopper H., et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998, 115:1317-1321.
7. Clemente M.G., Musu M.P., Troncone R., et al. Enterocyte actin autoantibody detection. A new diagnostic tool in celiac disease. Diagnosis: results of a multicenter study. Am J Gastroenterol 2004, 99:1551-1556.
8. Pedreira S., Sugai E., Moreno M.L., et al. Significance of smooth muscle/anti-actin autoantibodies in celiac disease. Acta Gastroenterol Latinoamer 2005, 37:58-66.
9. National Institutes of Health Consensus Development Conference Statement on Celiac Disease. Gastroenterology 2005; 128: S1-S9.
10. Bai J.C., Zeballos E., Fried M., et al. Celiac disease. WGO-OMGE Practice Guidelines. World Gastroenterol News 2005, 10:S1-S8.
11. Fabiani E., Catassi C. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease results of an international multi-centre study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol 2001, 13:659-665.
12. Sategna-Guidetti C., Grosso S., Bruno M., et al. Reliability of immunologic markers of celiac sprue in the assessment of mucosal recovery after gluten withdrawal. J Clin Gastroenterol 1996, 23:101-104.
13. Tursi A., Bandimarte G., Giorgetti G.M., et al. Endoscopic and histological findings in the duodenum of adults with celiac disease before and after changing to a gluten-free diet: a 2 year prospective study. Endoscopy 2006, 38:702-707.
14. Wahab P.J., Meijer J.W., Mulder C.J. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 2002, 118:459-463.
15. Ciclitira P.J. Celiac disease: a technical review. Gastroenterology 2001, 120:1526-1540.
16. Nachman F., Mauriño E., Vázquez H., et al. Quality of life in celiac disease patients. Prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liv Dis 2009, 41:15-25.
17. Vahedi K., Mascart F., Mary J.Y., et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003, 98:1079-1087.
18. Dickey W., Hughes D.F., Mc Millan S.A. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 2000, 95:712-714.
19. Valentini R.A., Andreani M.L., Corazza G.R., et al. IgA endomysium antibody: a valuable tool in the screening of coeliac disease but not its follow-up. Ital J Gastroenterol 1994, 26:279-282.
20. Liu E., Bao F., Barriga K., Miao D., et al. Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease. Clin Gastroenterol Hepatol 2003, 1:356-362.
21. Marsh M.M. Gluten histocompatibility complex and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (" celiac sprue" ). Gastroenterology 1992, 102:230-254.
22. Rostami K., Kerckhaert J., Tiemessen R., von Blomberg M.E., Meijer J.W.R., Mulder C.J.J. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 1999, 94:888-894.
23. Niveloni S., Mauriño E., Pedreira S., et al. Clinical picture. The global village of coeliac disease. Perspectives on coeliac disease 2005, vol. II:23-44. AJC Press.
24. Niveloni S., Sugai E., Cabanne A., et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pre-test probability of disease. Clin Chem 2007, 53:2186-2192.
25. Ciacci C., Cirillo M., Cavallaro R., Mazzacca G. Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 2002, 66:178-185.
26. Leffler D.A., Edwards George J.B., Dennis M., et al. A prospective comparative study of five measures of gluten-free diet adherence in adults with coelic disease. Alim Pharmacol Ther 2007, 26:1227-1235.
27. Kaukinen K., Sulkanen S., Maki M., Collins P. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol 2002, 14:311-315.
28. Bazzigaluppi E., Roggero P., Parma B., et al. Antibodies to recombinant human tissue-transglutaminase in coelic disease: diagnostic effectiveness and decline pattern after gluten-free diet. Dig Liver Dis 2006, 38:98-102.
29. Ciacci C., Cavallaro R., Della Valle N., DóArgento C. The use of serum tTG-ab assay in patients on gluten-free diet as a measure of dietary compliance. Gastroenterology 2002, 122:588.
30. Midhagen G., Aberg A.K., Olcén, et al. Antibody levels in adult patients with coeliac disease during gluten-free diet: a rapid initial decrease of clinical importance. J Intern Med 2004, 256:519-524.
31. Carroccio A., Brusca I., Iacono G., et al. IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study. Dig Liv Dis 2007, 39:818-823.
32. Sugai E., Vázquez H., Nachman, et al. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol 2006, 4:1112-1117.